National negotiated drugs landing in Hainan "full moon"

Source: Health News August 5, 2016 our reporter Liu Zelin □ since July 1, Hainan Province has listed three kinds of patent drugs and imported drugs after the national negotiation and price reduction into the new rural cooperative medical reimbursement catalogue On July 31, when the national negotiated drugs landed in the "full moon" of Hainan, the reporter found that the patients of NCMS benefited significantly, but for all patients, there are still some problems to be solved At present, a number of medical institutions such as Hainan people's Hospital, Hainan traditional Chinese medicine hospital and Haikou People's hospital have purchased and used the above-mentioned drugs online Hainan people's hospital is the hospital that uses the most drugs negotiated by the state in the province Li pharmacist of the hospital introduced that because of the high price, gefitinib tablets (Iressa) were almost not used before After the national negotiation and price reduction, 8 boxes were used in July; ecmetinib hydrochloride tablets (Kemena) used 4 or 5 boxes every month before, increasing to 18 in July In the past, about 200 boxes of tenofovir dipivoxil fumarate tablets were used every month, and more than 350 boxes were used in July Wang Meiqing, deputy director of oncology surgery of Haikou People's Hospital, said that taking gefitinib tablet as an example, patients taking the drug could spend more than 9000 yuan less per month due to the price reduction of the drug According to the reimbursement ratio of 60% of the new rural cooperative referral patients, the actual monthly cost of the new rural cooperative patients is 2919.6 yuan, and the benefit is very obvious According to the relevant regulations of Hainan Province, after the reimbursement of NCMS, it can also enter the serious illness insurance reimbursement After that, if the remaining part of the personal self payment is in line with the civil affairs assistance policy, assistance may also be given from the civil affairs department in accordance with the relevant provisions of medical assistance According to the requirements of Hainan Province, exetinib hydrochloride and gefitinib tablets are only used in the oncology department of the second and third level general hospitals, the third level hospital of traditional Chinese medicine and the tumor hospital of Hainan Province Tenofovir fumarate dipivoxil tablets, as a drug for the treatment of chronic hepatitis B, are only used in the infectious department or infectious department of the second and third level general hospitals, the third level hospital of traditional Chinese medicine and the tumor hospital of Hainan Province If the medical institution does not meet the above requirements uses the medicine, the new rural cooperative medical institution will refuse to pay the reimbursement amount of the medicine advanced by the medical institution for the patient In order to promote hierarchical diagnosis and treatment, and guide patients to the grass-roots level for treatment and hospitalization, Hainan Province stipulates that each city (county) can determine one or two public health centers or standardized central health centers that are satisfactory to the masses With the approval of the new rural cooperative agency, 3 The use authority of generic drugs shall be delegated to township level medical institutions, and payment shall be made according to the disease type, not according to the medical policy of fee limit, and not included in the assessment of drug proportion index According to the relevant requirements of Hainan Province, the new rural cooperative medical intelligent audit system will strictly review the three drugs' indications If it is found that the drugs are not used according to the indications, the new rural cooperative medical agency will refuse to pay the reimbursement amount of the drugs advanced by the medical institution for the patients Tenofovir dipivoxil has a wide range of indications for the treatment of chronic hepatitis B patients, has a good safety for pregnant women, and can be used for the treatment of various drug-resistant chronic hepatitis B patients Exetane and gefitinib can improve the accuracy of treatment and prolong the survival of patients with NSCLC Wang Meiqing introduced that exetane or gefitinib is not effective for all lung cancer patients, only for patients with epidermal growth factor mutations, with specific targets and characteristics of the population It is necessary to determine whether to use national negotiated drugs through gene testing, and determine that patients have corresponding disease indicators before use This part of patients accounts for about 1 / 3 of lung cancer patients But the reporter learned that gene testing is not available in every hospital Even a top three hospital like Haikou People's hospital does not have the ability of gene testing Moreover, gene testing costs more than 3000 yuan each time, which has not been included in the reimbursement scope of Hainan new rural cooperative Some patients with poor families can't bear these costs and will give up testing, which means it's difficult to determine whether these patients have disease indications